Aileron Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy ALRN

*Your capital is at risk

$2.11

+0 (+0%)

At Close: Apr 09, 2025

Currently predicting for Mon, 8 Jun 2026

ALRN Prediction Chart

ALRN Predictions History

Latest community submissions for ALRN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
RandolphAshey	Jul 20, 2020	Bearish	$1.08	V	—
NameNotImportant Pro	May 6, 2019	$1.75 -94.70%	$1.65	X	93.94%
Ted.Newman.106352	Apr 4, 2019	$1.81 -94.92%	$1.78	V	98.31%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALRN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT AILERON THERAPEUTICS INC

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by